|
Lipitor Scripts Sink to 2002 Level as Other Statins Rise
Generic versions of Merck’s Zocor captured a 30 percent share of all prescriptions dispensed in the U.S. market for single-dose statins in 2007, while Pfizer’s market-leading statin Lipitor lost ground, with total scripts falling 12 percent to 65.1 million, its lowest level since 2002, according to data from IMS Health.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives